Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blockers in anxiety disorders.

P E Hayes1, S C Schulz

  • 1Department of Pharmacy and Pharmaceutics, Virginia Commonwealth University, Medical College of Virginia, Richmond 23298.

Journal of Affective Disorders
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National institute of mental health clinical research career opportunities.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

The impact of parent socio-economic status on executive functioning and cortical morphology in individuals with schizophrenia and healthy controls.

Psychological medicine·2013
Same author

Striatal function in relation to negative symptoms in schizophrenia.

Psychological medicine·2011
Same author

Cognitive deficits in recent-onset and chronic schizophrenia.

Journal of psychiatric research·2009
Same author

First-episode psychosis: a clinical approach.

The Journal of the American Board of Family Practice·2000
Same author

Schizophrenia research: a progress report, summarizing proceedings of the 1999 International Congress on Schizophrenia Research.

Schizophrenia bulletin·2000

Beta-blockers are not routinely recommended for generalized anxiety or panic disorder. Propranolol may offer symptomatic relief for physical anxiety symptoms when used alongside other treatments, but further research is needed.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Generalized anxiety disorder and panic disorder are common psychiatric conditions.
  • Beta-blockers are a class of drugs often used for cardiovascular conditions.

Purpose of the Study:

  • To evaluate the efficacy of beta-blockers, specifically propranolol, in treating anxiety and panic disorders.
  • To determine the role of beta-blockers in managing physical symptoms associated with anxiety.

Main Methods:

  • Review of studies examining the antianxiety and antipanic properties of beta-blockers.
  • Analysis of preliminary research on propranolol's efficacy in panic disorder.

Main Results:

  • Current evidence does not support the routine use of beta-blockers for generalized anxiety disorder or panic disorder.

Related Experiment Videos

  • Propranolol may be effective for physical symptoms like palpitations and tachycardia in some patients, particularly when combined with benzodiazepines or other treatments.
  • Preliminary research on propranolol for panic disorder has yielded discouraging results.

    • Conclusions:

    • Beta-blockers are not a first-line treatment for generalized anxiety or panic disorder.
    • Propranolol might provide symptomatic relief for specific physical complaints in anxiety disorders, but requires further investigation.
    • Caution is advised when using beta-blockers in patients with co-occurring depression due to potential mood side effects.